Patents by Inventor Mads Röpke

Mads Röpke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FVII OR FVIIA VARIANTS
    Publication number: 20100330669
    Abstract: Variants of FVII or FVIIa comprising at least one amino acid modification in position 196, 237, or 341 relative to hFVII or hFVIIa. The variants exhibit an increased clotting activity, i.e. reduced clotting time, compared to rhFVIIa.
    Type: Application
    Filed: May 5, 2010
    Publication date: December 30, 2010
    Inventors: Kim Vilbour Andersen, Mads Röpke, Jesper Mortensen Haaning, Steven Glazer
  • FVII or FVIIa variants
    Patent number: 7771996
    Abstract: Variants of FVII or FVIIa comprising at least one amino acid modification in position 196, 237 or 341 relative to hFVII or hFVIIa. The variants exhibit an increased clotting activity, i.e. reduced clotting time, compared to rhFVIIa.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: August 10, 2010
    Assignee: Bayer Healthcare LLC
    Inventors: Kim Vilbour Andersen, Mads Röpke, Jesper Mortensen Haaning, Steven Glazer
  • Method for the treatment of neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (G-CSF) variant
    Publication number: 20090203601
    Abstract: The invention relates to a method for treating or preventing neutropenia in a patient receiving chemotherapy by administering a multi-PEGylated granulocyte colony stimulating factor (G-CSF) variant on the same day that chemotherapy is administered.
    Type: Application
    Filed: November 25, 2008
    Publication date: August 13, 2009
    Inventors: Bobby Soni, Torben Straight Nissen, Mads Roepke, David Gilfoyle